Maximus (NYSE:MMS) Stock Rating Lowered by StockNews.com

StockNews.com cut shares of Maximus (NYSE:MMS) from a buy rating to a hold rating in a research report sent to investors on Thursday.

Maximus Trading Up 2.8 %

MMS opened at $74.50 on Thursday. The company has a fifty day moving average price of $86.50 and a two-hundred day moving average price of $87.57. Maximus has a 1-year low of $71.75 and a 1-year high of $93.97. The company has a market cap of $4.49 billion, a P/E ratio of 14.90 and a beta of 0.77. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59.

Maximus Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Saturday, November 30th. Investors of record on Friday, November 15th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.61%. The ex-dividend date of this dividend was Friday, November 15th. Maximus’s dividend payout ratio (DPR) is currently 24.00%.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,363 shares of the firm’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $92.56, for a total value of $126,159.28. Following the transaction, the insider now directly owns 6,567 shares of the company’s stock, valued at approximately $607,841.52. This trade represents a 17.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.40% of the company’s stock.

Institutional Investors Weigh In On Maximus

Hedge funds and other institutional investors have recently made changes to their positions in the business. Inspire Advisors LLC boosted its stake in Maximus by 1.4% during the 2nd quarter. Inspire Advisors LLC now owns 8,768 shares of the health services provider’s stock valued at $751,000 after purchasing an additional 121 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Maximus by 4.5% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 3,179 shares of the health services provider’s stock valued at $272,000 after purchasing an additional 136 shares in the last quarter. Petrus Trust Company LTA boosted its position in shares of Maximus by 2.7% during the third quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares during the last quarter. WR Wealth Planners LLC grew its holdings in Maximus by 4.6% during the second quarter. WR Wealth Planners LLC now owns 4,525 shares of the health services provider’s stock worth $388,000 after buying an additional 198 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in Maximus by 224.5% in the 2nd quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the last quarter. 97.21% of the stock is owned by institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.